“Blueprinting” thrombogenicity and antithrombotic drug response at the bedside in patients presenting emergently with symptoms of acute stroke

External Quality Assurance of Platelet Function Assays: Results of the College of American Pathologists Proficiency Testing Program

“…8,15,16 It could provide more balanced views, including some published in this journal, to the specific issues raised about Plate-letMapping analysis, 11 and it should mention the described potential value of PlateletMapping in various clinical settings. [5][6][7][8]17 The above references show that the accuracy of the device in experienced hands has been established over and over again, and the findings are in line with those for other viscoelastic tests. Unpublished data from a study that we conducted with an independent good laboratory practice (GLP), thirdparty research institution actually show higher levels of accuracy and in certain settings better clinical utility than those of other technologies (poster submitted to 2019 Internation-al Society on Thrombosis and Haemostasis [ISTH] conference).…”

Ischemic stroke mimics: A comprehensive review

“…Hypertension 66.8% (20074/30035) vs. 41.1% (3434/8347) [11,14,15,19,20,21,23,24,28,[30][31][32][33][34]37,38,[40][41][42]47,48,50,52,23,[55][56][57][58][59]61,64,65,67,68,70,71], dyslipidaemia 38% (9891/26005) vs. 23.6% (1585/6717) [14,15,19,20,23,28,[32][33][34]37,40,41,48,50,52,53,…”

Real-time monitoring of intravenous thrombolysis in acute ischemic stroke using rotational thromboelastometry: a feasibility pilot study

“…Although ROTEM's clinical main area of application is point-of-care assessment in anesthesiology, it has also been used to evaluate whole blood coagulation in patients with ischemic stroke [15][16][17][18][19][20]. However, both main objectives and study designs differed and no dynamic coagulation profiling with outcome prediction has yet been performed.…”